Recent Articles By The Author
The biotech is Paratek Pharmaceuticals and it presents itself as a good covered call play.
The market seems to be overlooking this trio of potential setbacks to stocks.
Concerns over the strength of the recovery in the jobs market and the rate of Covid-19 cases are reasons for caution despite a resurgent market.
The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.
BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.